Dendreon (DNDN) Completes Submission of Biologics License Application for PROVENGE
Dendreon (Nasdaq: DNDN) Completes Submission of Biologics License Application for PROVENGE
You May Also Be Interested In
- UPDATE: Angelo, Gordon to Acquire Benihana (BNHN) for $16.30/Share in Cash
- Medicis (MRX) Gets Verbal Notice of Allowance for ZYCLARA Patent on Actinic Keratosis
- Notable Analyst Rating Changes 05/18: (MS) (MM) (PBR) Upgraded; (CAVM) (PWER) (CY) Downgraded
Create E-mail Alert Related Categories
FDA, Hot ListSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
